We found that DM patients have significantly increased serum concentration of IL-6, TGF-β, and IL-23 in comparison with healthy controls (P = 0.0011, P = 0.0097, and P = 0.0031, resp., Figures 3(a), 3(b), and 3(d)). Here, TGFB1 is linked to dermatomyositis.